Effectiveness of vericiguat in heart failure across ejection fraction phenotypes: a comprehensive meta-analytic trial sequential analysis and meta-regression analysis
Ibrahim Khalil, M. Rafiqul Islam, Manisha Das, Sunjida Amin Promi, Sajjad Ghanim Al-Badri, Sakib Abrar, Afsana Rahman Maliha, Avijit Debnath, Md Ekramul Islam, AKM Mushfiquzzaman, Md. Imran Hossain · 2026
Read Effectiveness of vericiguat in heart failure across ejection fraction phenotypes: a comprehensive meta-analytic trial sequential analysis and meta-regression analysis by Ibrahim Khalil, M. Rafiqul Islam, Manisha Das, Sunjida Amin Promi, Sajjad Ghanim Al-Badri, Sakib Abrar, Afsana Rahman Maliha, Avijit Debnath, Md Ekramul Islam, AKM Mushfiquzzaman, Md. Imran Hossain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13354362.txt.
Description
Ibrahim Khalil led a 2026 meta-study of vericiguat in heart failure across ejection fraction phenotypes. The drug stimulates soluble guanylate cyclase to ease cardiac stress, and it has shown promise when ejection fraction is reduced. Its value when ejection fraction is preserved, however, stayed unclear, and other heart failure types may need other care.
The team joined trials using trial sequential study and meta-fit, separating reduced and preserved ejection fraction groups. The study tests whether the overall benefit holds in each phenotype or fades in one of them. Doctors gain a clearer basis for deciding which heart failure people, if any, should receive vericiguat.
Catalog record
| CREATOR | Ibrahim Khalil, M. Rafiqul Islam, Manisha Das, Sunjida Amin Promi, Sajjad Ghanim Al-Badri, Sakib Abrar, Afsana Rahman Maliha, Avijit Debnath, Md Ekramul Islam, AKM Mushfiquzzaman, Md. Imran Hossain |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |